|
1.
|
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
- Blackburn, Matthew J
- Chitalia, Ami
- Dilawari, Asma
- Gallagher, Christopher
- Lynce, Filipa
- Mohebtash, Mahsa
- Tiwari, Shruti R
Year: 2021
Citation: - Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
- MedStar Franklin Square Cancer Center at Loch Raven Campus
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Hematology & Oncology Fellowship
- Hematology and Oncology
Medline publication type:
All authors: - Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
|
|
2.
|
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
- Asch, Federico M
- Barac, Ana
- Lynce, Filipa
- Swain, Sandra M
Year: 2017
Citation: - Oncologist. 22(5):518-525, 2017 May
Institution:
- MedStar Heart & Vascular Institute
- Washington Cancer Institute
Medline publication type:
All authors: - Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
|